Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Geovax Labs (GOVX)

Geovax Labs (GOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Roth MKM Sticks to Their Buy Rating for GeoVax Labs (GOVX) Tipranks - Wed Oct 15, 7:30AM CDT

Roth MKM analyst Jonathan Aschoff maintained a Buy rating on GeoVax Labs today and set a price target of $14.00. The company’s shares closed yesterday at $0.56.Elevate Your Investing Strategy: Take advantage...

GOVX : 0.3771 (-1.69%)
Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities PR Newswire - Wed Jul 16, 5:51PM CDT

Equity Insider News Commentary

ONCY : 0.9921 (+1.16%)
ZLAB : 19.50 (-2.26%)
GOVX : 0.3771 (-1.69%)
SLS : 1.7400 (unch)
ONC.TO : 1.42 (+2.16%)
OSTX : 1.9200 (+5.49%)
ZAILF : N/A (N/A)
Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities Newswire.ca - Wed Jul 16, 5:51PM CDT

/CNW/ -- As lawmakers weigh potential cuts to scientific research funding, the outlook for developing cancer cures faces growing uncertainty. The situation is...

ONCY : 0.9921 (+1.16%)
ZLAB : 19.50 (-2.26%)
GOVX : 0.3771 (-1.69%)
SLS : 1.7400 (unch)
ONC.TO : 1.42 (+2.16%)
OSTX : 1.9200 (+5.49%)
World Cancer Day Sparks Big Questions About Pollution, Genetics, and Innovation BayStreet.ca - Thu Feb 27, 8:58AM CST

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – As World Cancer Day (Feb. 4) fades into the rearview, attention is shifting to the latest discussions...

ONCY : 0.9921 (+1.16%)
ZNTL : 1.3900 (-0.71%)
NYT : 64.75 (+1.11%)
ABSI : 3.58 (-4.02%)
GOVX : 0.3771 (-1.69%)
ONC.TO : 1.42 (+2.16%)
GSK : 48.41 (-0.33%)
New Vaccine Technologies Lead the Charge as Global Immunization Efforts Evolve BayStreet.ca - Wed Dec 18, 2024

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – According to the World Health...

PCVX : 46.48 (+0.89%)
BVAXF : 0.1498 (-3.91%)
BIOV.CN : 0.1900 (-9.52%)
GILD : 121.22 (-1.14%)
GOVX : 0.3771 (-1.69%)
ARCT : 7.13 (+4.39%)
GeoVax Labs, Inc. Secures U.S. Patent Notice of Allowance for Tumor Immunotherapy Technology Quiver Quantitative, Inc. - Mon Dec 9, 2024

GeoVax Labs receives patent allowance, enhancing its intellectual property for cancer immunotherapy using its unique viral vector platform.Quiver AI SummaryGeoVax Labs, Inc. announced that the U.S. Patent...

GOVX : 0.3771 (-1.69%)
Author
3 Penny Stocks Ready to Break Out in 2025 MarketBeat - Fri Nov 29, 2024

Vuzix, GeoVox Labs, and Cardiol Therapeutics emerged as notable penny stocks late in 2024 for their potential to scale operations and launch new products.

VUZI : 2.77 (+0.36%)
CRDL : 1.0500 (+9.22%)
GOVX : 0.3771 (-1.69%)
GeoVax Labs, Inc. CEO David Dodd to Present at NobleCon20 Conference Quiver Quantitative, Inc. - Tue Nov 26, 2024

GeoVax Labs announces CEO David Dodd will present at NobleCon20 on corporate updates and clinical trials.Quiver AI SummaryGeoVax Labs, Inc., a biotechnology company focused on human vaccines and cancer...

GOVX : 0.3771 (-1.69%)
GeoVax, SIGA Jump After WHO Extends Mpox Public Emergency Status: Here’s What Retail Thinks Stocktwits - Fri Nov 22, 2024

Emergent Biosolutions and Chimerix also saw marginal gains after the announcement.

SIGA : 6.20 (-2.21%)
EBS : 11.90 (-1.24%)
GOVX : 0.3771 (-1.69%)
CMRX : 8.54 (-0.12%)
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth FinancialNewsMedia - Thu Jun 20, 2024

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GOVX),(NYSE:GSK),(NASDAQ:AZN),(NYSE:MRK) EQNX::TICKER_END

ONCY : 0.9921 (+1.16%)
AZN : 90.18 (+0.17%)
MRK : 99.72 (-1.16%)
GOVX : 0.3771 (-1.69%)
ONC.TO : 1.42 (+2.16%)
GSK : 48.41 (-0.33%)

Barchart Exclusives

Rate Decision, Tech Earnings and Other Key Things to Watch this Week Barchart - Sun Dec 7, 12:00PM CST
Markets face the year's final major policy week as the Federal Reserve's December meeting Wednesday afternoon will determine whether the central bank delivers another rate cut or pauses its easing cycle amid mixed economic signals and persistent inflation concerns. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot